Clinical Trials Directory

Trials / Completed

CompletedNCT04325243

Sildenafil Citrate and Intrapartum Fetal Distress

Efficacy of Sildenafil Citrate to Reduce the Rate of Cesarean Section for Intrapartum Fetal Distress During Induction of Labor

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
410 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Induction of labour (IOL) is done for 20% of pregnancies for various maternal and fetal indications and nearly 20% of labour inductions end up in caesarean section. The most common causes are failed induction and intrapartum fetal distress. In spite of significant advances in methods of IOL and intrapartum fetal monitoring, no interventions are proven to reduce the development of intrapartum fetal distress

Conditions

Interventions

TypeNameDescription
DRUGSildenafil 50 mg50 mg oral Sildenafil tablet
DRUGPlacebo oral tabletplacebo tablets of the same shape, color and size of Sildenafil tablets manufactured in the Department of Pharmaceuticals, Faculty of Pharmacy

Timeline

Start date
2020-09-01
Primary completion
2022-04-30
Completion
2022-07-31
First posted
2020-03-27
Last updated
2023-01-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04325243. Inclusion in this directory is not an endorsement.

Sildenafil Citrate and Intrapartum Fetal Distress (NCT04325243) · Clinical Trials Directory